MYCN and neuroblastoma: Upregulation of DHX9 protein in high-risk neuroblastomas contingent on MYCN amplification was confirmed by re-analyzing a published mass spectrometry data set35 from 34 (12 with and 22 lacking MYCN amplifications) independent neuroblastoma samples (p = 0.01, Fig. 4e).